Jim Allison.
Co-founder of Immuno-oncology therapies
He pioneered immune checkpoint therapy for cancer.
His work revolutionised cancer treatment.
In 1948, he was born in the USA.
In 1973, he earned his PhD in Biochemistry from the University of Texas.
In 1994, he discovered CTLA-4 blockade for cancer therapy.
1. Immune checkpoint therapy, a method that unleashes the immune system to attack tumors.
2. It improved survival in multiple cancers.
3. It led to new classes of cancer drugs.
In 2018, he received the Nobel Prize in Physiology or Medicine.
His research changed cancer treatment worldwide.
He currently leads research at the MD Anderson Cancer Center.
Want to know more stories?
Visit Jim Allison.